Novel ankyrin repeat domain family pseudogene (ENSG00000286406)

The ENSG00000286406 locus is annotated as a **pseudogene** related to the ankyrin repeat domain family[5]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional; they may originate from gene duplication or retrotransposition and accumulate mutations that preclude their protein-coding capacity[2][6]. Most pseudogenes, including this one, do not produce functional proteins, are not drug targets, and have no direct roles in disease or therapy[6]. While ankyrin repeat domains are common protein–protein interaction motifs in various functional proteins, the pseudogene form lacks evidence of such activity[3]. There is no evidence to indicate that ENSG00000286406 encodes a functional protein or participates in processes relevant to therapeutic targeting. Key clarifications: - **Not a drug target:** Pseudogenes are generally not considered therapeutic targets because they do not encode active proteins or functional RNA products relevant to drug action[6]. - **No mechanistic or disease relevance:** No roles in disease, no interacting drugs, mechanisms, or biomarkers are recorded for this sequence[5][6]. - **Classification issues:** Because this is a pseudogene, it is not strictly a "molecule/receptor" as usually meant in the context of drug discovery or pharmacology. The field may use nomenclature such as "member A13, pseudogene" or similar for other ankyrin repeat-related pseudogenes[1]. Summary: ENSG00000286406 is a pseudogene with no evidence for functionality as a therapeutic target, no druggability, and no disease association. Its only relevance is as a genomic artifact related to the ankyrin repeat domain family[2][5][6].

Other names

ankyrin repeat domain family pseudogeneENSG00000286406